Literature DB >> 34120504

COVID Arm: Delayed Hypersensitivity Reactions to SARS-CoV-2 Vaccines Misdiagnosed as Cellulitis.

Aleksandra L Lindgren1, Andrea Hui Austin2, Kathleen M Welsh2.   

Abstract

The term "COVID arm" has been coined to describe a harmless delayed hypersensitivity reaction occurring approximately a week after administration of the novel SARS-CoV-2 mRNA vaccine. It appears as a red, warm, pruritic, indurated, or swollen area in the vicinity of the vaccine site. These reactions, especially if accompanied by systemic symptoms, have been mistaken for cellulitis. We report 3 cases of COVID arm, 2 of which were mistaken for cellulitis. Distinguishing features of COVID arm from cellulitis include pruritus as a common finding, occurrence approximately a week after vaccination, a lack of progression of symptoms, rapid response to topical steroids, and/or spontaneous resolution usually over 4 to 5 days.Practice Points:• Patients receiving SARS-CoV-2 vaccines may experience delayed hypersensitivity reactions characterized by erythema, swelling, and itching occurring near the vaccination site (COVID arm), approximately a week after vaccination.• Clinicians can distinguish SARS-CoV-2 vaccine reactions from cellulitis by the time of onset (approximately a week vs 5 days), by the lack of progression of symptoms, and resolution over 4 to 5 days.• Severe cases of COVID arm may be treated with topical steroids.

Entities:  

Keywords:  COVID arm; COVID-19 vaccine; T-cell mediated; delayed hypersensitivity reactions; mRNA vaccines; post-vaccination reactions; skin and soft tissue infection; treatment of COVID arm; vaccine allergy; vaccine safety

Mesh:

Substances:

Year:  2021        PMID: 34120504      PMCID: PMC8202256          DOI: 10.1177/21501327211024431

Source DB:  PubMed          Journal:  J Prim Care Community Health        ISSN: 2150-1319


  16 in total

Review 1.  Adverse reactions to vaccines practice parameter 2012 update.

Authors:  John M Kelso; Matthew J Greenhawt; James T Li; Richard A Nicklas; David I Bernstein; Joann Blessing-Moore; Linda Cox; David Khan; David M Lang; John Oppenheimer; Jay M Portnoy; Christopher R Randolph; Diane E Schuller; Sheldon L Spector; Stephen A Tilles; Dana Wallace
Journal:  J Allergy Clin Immunol       Date:  2012-05-16       Impact factor: 10.793

Review 2.  Cellulitis: A Review.

Authors:  Adam B Raff; Daniela Kroshinsky
Journal:  JAMA       Date:  2016-07-19       Impact factor: 56.272

3.  Induration at or near injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data.

Authors:  Katrin S Kohl; Wikke Walop; Jane Gidudu; Leslie Ball; Scott Halperin; Sandra Jo Hammer; Paul Heath; Renald Hennig; Edward Rothstein; Anne Schuind; Frederick Varricchio
Journal:  Vaccine       Date:  2007-05-08       Impact factor: 3.641

4.  Cellulitis at injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data.

Authors:  Scott Halperin; Katrin S Kohl; Jane Gidudu; Leslie Ball; Sandra Jo Hammer; Paul Heath; Renald Hennig; Jerry Labadie; Edward Rothstein; Anne Schuind; Frederick Varricchio; Wikke Walop
Journal:  Vaccine       Date:  2007-05-11       Impact factor: 3.641

5.  Case Report of Subcutaneous Nodules and Sterile Abscesses Due to Delayed Type Hypersensitivity to Aluminum-Containing Vaccines.

Authors:  Christine T Lauren; Donald V Belsito; Kimberly D Morel; Philip LaRussa
Journal:  Pediatrics       Date:  2016-10       Impact factor: 7.124

6.  Immediate and delayed allergic contact reactions to polyethylene glycol.

Authors:  A A Fisher
Journal:  Contact Dermatitis       Date:  1978-06       Impact factor: 6.600

7.  Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group.

Authors:  H D Davies; A McGeer; B Schwartz; K Green; D Cann; A E Simor; D E Low
Journal:  N Engl J Med       Date:  1996-08-22       Impact factor: 91.245

Review 8.  Vaccine-associated hypersensitivity.

Authors:  Michael M McNeil; Frank DeStefano
Journal:  J Allergy Clin Immunol       Date:  2018-02       Impact factor: 10.793

9.  Costs and Consequences Associated With Misdiagnosed Lower Extremity Cellulitis.

Authors:  Qing Yu Weng; Adam B Raff; Jeffrey M Cohen; Nicole Gunasekera; Jean-Phillip Okhovat; Priyanka Vedak; Cara Joyce; Daniela Kroshinsky; Arash Mostaghimi
Journal:  JAMA Dermatol       Date:  2017-02-01       Impact factor: 10.282

10.  Herpes zoster vaccine (Zostavax®): Cellulitic injection site reaction or bacterial cellulitis?

Authors:  Ian F Cook
Journal:  Hum Vaccin Immunother       Date:  2016-10-27       Impact factor: 3.452

View more
  4 in total

Review 1.  Erythema Migrans-like COVID Vaccine Arm: A Literature Review.

Authors:  Gaia Fasano; Luigi Bennardo; Silvana Ruffolo; Maria Passante; Azzurra Gaia Ambrosio; Maddalena Napolitano; Eugenio Provenzano; Steven Paul Nisticò; Cataldo Patruno
Journal:  J Clin Med       Date:  2022-02-01       Impact factor: 4.241

2.  Cutaneous reactions to COVID-19 vaccines: A review.

Authors:  See Wei Tan; Yew Chong Tam; Shiu Ming Pang
Journal:  JAAD Int       Date:  2022-02-17

Review 3.  The Impact of COVID-19 Pandemic on Dermatological Conditions: A Novel, Comprehensive Review.

Authors:  Gehan A Pendlebury; Peter Oro; William Haynes; Drew Merideth; Samantha Bartling; Michelle A Bongiorno
Journal:  Dermatopathology (Basel)       Date:  2022-06-29

Review 4.  Cutaneous adverse reactions following COVID-19 vaccinations: A systematic review and meta-analysis.

Authors:  Mohammad Shafie'ei; Marzieh Jamali; Zahra Akbari; Nastaran Sarvipour; Mohadese Ahmadzade; Najmeh Ahramiyanpour
Journal:  J Cosmet Dermatol       Date:  2022-08-01       Impact factor: 2.189

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.